CN

TAI HENG OFFICIAL NOTICE

source: author: Publication time:2021-12-03 browse:497

Notice

In order to meet our rapid development needs, our new R&D center in Minhang District, Shanghai will be operational in January, 2022. Our current FDA inspected GMP facility (FEI 3006986091) in Longwu Road, Shanghai remains operational for all existing API products, including but not limit to production, packaging, testing and other related production activities. Therefore, the new site will not change the relative company information previously registered in USFDA in any way, nor will it affect the production and operation of our API products.


ADMINISTRATION DEPARTMENT

of TAI HENG INDUSTRY CO., LTD

执行时间:0.079827785491943秒 查询数据库10次 内存使用:1.069 mb - 256 kb = 838.703 kb 当前模式:developer